手机验证
用于ee值测定HPLC标记试剂—上海甄准
手性分子的两个对映体中,各对映体都把平面偏振光旋转到一定的角度,其数值相同但方向相反,这种性质称为光学活性。化合物样品的对映体组成可用术语“对映体过量(enantiomeric excess)”或“ee%”来描述。它表示一个对映体对另一个对映体的过量,通常用百分数表示。
上海甄准生物提供用于ee值测定HPLC标记试剂。
产品信息:
货号 |
中文品名 |
英文品名 |
CAS No |
纯度 |
规格 |
32219048 |
(1R,2R)-2-(蒽-2,3-二甲酰亚胺基)环己甲酸 |
(1R,2R)-2-(Anthracene-2,3-dicarboximido)cyclohexanecarboxylic Acid |
446044-44-6 |
>980%(T) |
100mg |
32219049 |
(1S,2S)-2-(蒽-2,3-二甲酰亚胺基)环己甲酸 |
(1S,2S)-2-(Anthracene-2,3-dicarboximido)cyclohexanecarboxylic Acid |
446044-45-7 |
>970%(HPLC) |
100mg |
32219050 |
2,3,4,6-四-O-乙酰基-β-D-吡喃葡萄糖异硫氰酸酯 |
2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl Isothiocyanate [for HPLC Labeling] |
14152-97-7 |
>980%(HPLC)(N) |
100mg/1g |
32219051 |
2,3,4,6-四-O-苯甲酰基-β-D-吡喃葡萄糖基异硫氰酸酯 |
2,3,4,6-Tetra-O-benzoyl-β-D-glucopyranosyl Isothiocyanate [for HPLC Labeling] |
132413-50-4 |
>980%(HPLC) |
100mg/1g |
32219052 |
Nα-(5-氟-2,4-二硝基苯基)-L-亮氨酰胺 |
Nα-(5-Fluoro-2,4-dinitrophenyl)-L-leucinamide [HPLC Labeling Reagent foree Determination] |
178065-29-7 |
>980%(HPLC) |
100mg |
32219053 |
Nα-(2,4-二硝基-5-氟苯基)-D-亮氨酰铵 |
Nα-(5-Fluoro-2,4-dinitrophenyl)-D-leucinamide [HPLC Labeling Reagent foree Determination] |
178065-30-0 |
>980%(HPLC) |
100mg/1g |
32219054 |
(S)-(+)-DBD-APy [=(S)-(+)-4-(N,N-二甲氨基磺酰)-7-(3-氨基吡咯烷-1-基)-2,1,3-苯并恶二唑] |
(S)-(+)-DBD-APy [=(S)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for eeDetermination] |
143112-50-9 |
>980%(HPLC) |
100mg |
32219055 |
(R)-(-)-DBD-APy [=(R)-(-)-4-(N,N-二甲氨基磺酰)-7-(3-氨基吡咯烷-1-基)-2,1,3-苯并恶二唑] |
(R)-(-)-DBD-APy [=(R)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for eeDetermination] |
143112-49-6 |
>980%(HPLC) |
100mg |
32219056 |
(S)-(+)-NBD-APy [=(S)-(+)-4-硝基-7-(3-氨基吡咯烷-1-基)-2,1,3-苯并恶二唑] |
(S)-(+)-NBD-APy [=(S)-(+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] |
143112-52-1 |
>980%(HPLC) |
100mg |
32219057 |
(R)-(-)-NBD-APy[ =(R)-(-)-4-硝基-7-(3-氨基吡咯烷-1-基)-2,1,3-苯并恶二唑] |
(R)-(-)-NBD-APy [=(R)-(-)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] |
143112-51-0 |
>980%(HPLC) |
100mg |
32219058 |
(S)-(-)-DBD-Pro-COCl [=(S)-(-)-4-(N,N-二甲氨基磺酰基)-7-(2-氯甲酰四氢吡咯-1-基)-2,1,3-苯并恶二唑] |
(S)-(-)-DBD-Pro-COCl [=(S)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] |
150993-63-8 |
>900%(HPLC) |
100mg |
32219059 |
(R)-(+)-DBD-Pro-COCl [=(R)-(+)-4-(N,N-二甲氨基磺酰基)-7-(2-氯甲酰四氢吡咯-1-基)-2,1,3-苯并恶二唑] |
(R)-(+)-DBD-Pro-COCl [=(R)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] |
150993-62-7 |
>950%(HPLC) |
100mg |
32219060 |
(R)-(+)-NBD-Pro-COCl [=(R)-(+)-4-硝基-7-(2-氯甲酰四氢吡咯-1-基)-2,1,3-苯并恶二唑] |
(R)-(+)-NBD-Pro-COCl [=(R)-(+)-4-Nitro-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] |
159717-69-8 |
|
100mg |
32219061 |
(S)-(-)-NBD-Pro-COCl [=(S)-(-)-4-硝基-7-(2-氯甲酰四氢吡咯-1-基)-2,1,3-苯并恶二唑] |
(S)-(-)-NBD-Pro-COCl [=(S)-(-)-4-Nitro-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] |
159717-68-7 |
>980%(HPLC) |
100mg |
32219062 |
(R)-(-)-DBD-Py-NCS [=(R)-(-)-4-(N,N-二甲氨基磺酰基)-7-(3-异硫氰酸基四氢吡咯-1-基)-2,1,3-苯并恶二唑] |
(R)-(-)-DBD-Py-NCS [=(R)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(3-isothiocyanatopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [for HPLC Labeling] |
163927-31-9 |
>980%(HPLC) |
100mg |
32219063 |
(S)-(+)-DBD-Py-NCS [=(S)-(+)-4-(N,N-二甲氨基磺酰基)-7-(3-异硫氰酸基四氢吡咯-1-基)-2,1,3-苯并恶二唑] |
(S)-(+)-DBD-Py-NCS [=(S)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(3-isothiocyanatopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [for HPLC Labeling] |
163927-32-0 |
>980%(HPLC) |
100mg |
32219064 |
(R)-(-)-NBD-Py-NCS [=(R)-(-)-4-(3-异硫氰酸基吡咯烷-1-基)-7-硝基-2,1,3-苯并恶二唑] |
(R)-(-)-NBD-Py-NCS [=(R)-(-)-4-(3-Isothiocyanatopyrrolidin-1-yl)-7-nitro-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] |
163927-29-5 |
>980%(HPLC) |
100mg |
32219065 |
(S)-(+)-NBD-Py-NCS [=(S)-(+)-4-(3-异硫氰酸基吡咯烷-1-基)-7-硝基-2,1,3-苯并恶二唑] |
(S)-(+)-NBD-Py-NCS [=(S)-(+)-4-(3-Isothiocyanatopyrrolidin-1-yl)-7-nitro-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] |
163927-30-8 |
>980%(HPLC) |
100mg |
32219066 |
Nα-(5-氟-2,4-二硝基苯基)-L-丙氨酰胺 |
Nα-(5-Fluoro-2,4-dinitrophenyl)-L-alaninamide [HPLC Labeling Reagent foree Determination] |
95713-52-3 |
>950%(HPLC) |
100mg/1g |
32219067 |
(R)-(+)-α-甲基苄基异氰酸酯 |
(R)-(+)-α-Methylbenzyl Isocyanate |
33375-06-3 |
>980%(GC) |
1g/5g/25g |
32219068 |
异氰酸(S)-(-)-α-甲基苄酯 |
(S)-(-)-α-Methylbenzyl Isocyanate |
14649-03-7 |
>950%(GC) |
1g/5g |
32219069 |
异氰酸(R)-(-)-1-(萘基)乙酯 |
(R)-(-)-1-(1-Naphthyl)ethyl Isocyanate |
42340-98-7 |
>900%(GC) |
1g/5g |
32219070 |
异氰酸(S)-(+)-1-(1-萘基)乙酯 |
(S)-(+)-1-(1-Naphthyl)ethyl Isocyanate |
73671-79-1 |
>950%(GC) |
1g/5g |
32219071 |
(R)-(-)-2-甲氧基-2-(1-萘基)丙酸 |
(R)-(-)-2-Methoxy-2-(1-naphthyl)propionic Acid |
63628-26-2 |
>990%(HPLC) |
100mg |
32219072 |
(S)-(+)-2-甲氧基-2-(1-萘基)丙酸 |
(S)-(+)-2-Methoxy-2-(1-naphthyl)propionic Acid |
102691-93-0 |
>990%(HPLC) |
100mg |
32219073 |
(1R,2R)-2-(萘-2,3-二甲酰亚胺基)环己甲酸 |
(1R,2R)-2-(Naphthalene-2,3-dicarboximido)cyclohexanecarboxylic Acid |
642995-15-1 |
>980%(HPLC)(T) |
100mg |
32219074 |
(1S,2S)-2-(萘-2,3-二甲酰亚胺基)环己甲酸 |
(1S,2S)-2-(Naphthalene-2,3-dicarboximido)cyclohexanecarboxylic Acid |
642995-16-2 |
>980%(HPLC)(T) |
100mg |
更多产品,更多优惠!请联系我们!
上海甄准生物科技有限公司
免费热线:400-002-3832
电话:021-6840 4353
传真:021-5897 9353
客服手机/QQ:15800340161
客服手机/QQ:13795317828
客服手机/QQ:13512172575
客服手机/QQ:13818641861
客服手机/QQ:13917991872
客服手机/QQ:13916577892
技术支持热线/QQ:13651665725
服务监督与投诉:18918753302
官网:www.zzstandard.com
E:yangshuyan@zzstandard.com
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。